First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 1: update on national regulatory frameworks pertinent to clinical is-Reference-Cited by-同舟云学术

First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 1: update on national regulatory frameworks pertinent to clinical is

Published:2016-01 Issue:1 Volume:23 Page:14-24
ISSN:0908-665X
Container-title:Xenotransplantation
language:en
Short-container-title:Xenotransplantation

Author:

Cozzi Emanuele¹²,Tönjes Ralf R.³,Gianello Pierre⁴,Bühler Léo H.⁵,Rayat Gina R.⁶,Matsumoto Shinichi⁷,Park Chung-Gyu⁸,Kwon Ivo⁸,Wang Wei⁹,O'Connell Philip¹⁰,Jessamine Stewart¹¹,Elliott Robert B.¹²,Kobayashi Takaaki¹³,Hering Bernhard J.¹⁴

Affiliation:

1. Department of Transfusion Medicine; Transplant Immunology Unit; Padua University Hospital; Padua Italy

2. CORIT (Consortium for Research in Organ Transplantation); Padua Italy

3. Division of Medical Biotechnology; Paul-Ehrlich-Institut; Federal Institute for Vaccines and Biomedicines; Langen Germany

4. Department of Health Sciences; Institute for Experimental and Clinical; Experimental Surgery and Transplantation; Catholic University of Louvain; Brussels Belgium

5. Department of Visceral Surgery; Hôpitaux Universitaires de Genève; Genève Switzerland

6. Faculty of Medicine and Dentistry; Department of Surgery; The Surgical-Medical Research Institute and Alberta Diabetes Institute; University of Alberta; Edmonton Canada

7. Otsuka Pharmaceutical Factory, Inc.; Tokushima Japan

8. Department of Microbiology and Immunology; Xenotransplantation Research Center; Seoul National University College of Medicine; Seoul Korea

9. Institute for Cell Transplantation and Gene Therapy; NHFPC Engineering Center for Transplantation Medicine; The 3rd Xiangya Hospital of Central South University; Changsha People Republic of China

10. Transplantation Unit; University of Sydney at Westmead Hospital; Westmead Australia

11. Medsafe Clinical Leadership Protection & Regulation Ministry of Health; Wellington; New Zealand

12. Diatranz Otsuka Ltd; Manukau; Auckland New Zealand

13. Department of Renal Transplant Surgery; Aichi Medical University School of Medicine; Nagakute JAPAN

14. Department of Surgery; Schulze Diabetes Institute; University of Minnesota; Minneapolis USA

Publisher

Wiley

Subject

Transplantation,Immunology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/xen.12222/fullpdf

Reference39 articles.

1. Islet cell xenotransplantation: a serious look toward the clinic;Samy;Xenotransplantation,2014

2. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets;Windt;Am J Transplant,2009

3. Long-Term Control of Diabetes in Immunosuppressed Nonhuman Primates (NHP) by the Transplantation of Adult Porcine Islets;Shin;Am J Transplant,2015

4. www.lctglobal.com

5. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 1: key ethical requirements and progress toward the definition of an international regulatory framework;Cozzi;Xenotransplantation,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell and Other Cell Therapies;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023

2. Improvements in pig agriculture through gene editing;CABI Agriculture and Bioscience;2022-06-21

3. Ecological and Organismic Body Politics: The Moratorium on Xenotransplantation in Australia;Species of Contagion;2022

4. Sir Bob Elliot—“In Memoriam”;Xenotransplantation;2020-09

5. Xenotransplantation in Australia: Development of the regulatory process;Xenotransplantation;2020-05